Total Payments
$4,426
2024 Payments
$667.30
Companies
16
Transactions
155
Medicare Patients
893
Medicare Billing
$76,181
Payment Breakdown by Category
Food & Beverage$4,424 (100.0%)
Education$1.81 (0.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,424 | 152 | 100.0% |
| Education | $1.81 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,341 | 42 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $518.18 | 25 | $0 (2023) |
| Janssen Biotech, Inc. | $503.42 | 13 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $379.96 | 17 | $0 (2023) |
| Ferring Pharmaceuticals Inc. | $366.43 | 13 | $0 (2023) |
| NESTLE HEALTHCARE NUTRITION INC. | $253.34 | 11 | $0 (2023) |
| Braintree Laboratories, Inc. | $243.34 | 13 | $0 (2022) |
| Ardelyx, Inc. | $228.30 | 6 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $226.79 | 2 | $0 (2022) |
| Merck Sharp & Dohme LLC | $97.06 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $667.30 | 7 | Janssen Biotech, Inc. ($271.44) |
| 2023 | $1,689 | 65 | ABBVIE INC. ($743.23) |
| 2022 | $1,465 | 55 | ABBVIE INC. ($268.95) |
| 2021 | $604.63 | 28 | Braintree Laboratories, Inc. ($172.41) |
All Payment Transactions
155 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $120.82 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/13/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $73.92 | General |
| Category: Neuroscience | ||||||
| 09/09/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $98.10 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $146.96 | General |
| Category: Immunology | ||||||
| 04/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $124.48 | General |
| Category: Immunology | ||||||
| 03/06/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: IMMUNOLOGY | ||||||
| 03/05/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $93.02 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/05/2023 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $118.92 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/27/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $120.76 | General |
| Category: IMMUNOLOGY | ||||||
| 10/19/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $137.68 | General |
| Category: IMMUNOLOGY | ||||||
| 10/02/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Gastroenterology | ||||||
| 09/20/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Gastroenterology | ||||||
| 08/31/2023 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/30/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.00 | General |
| Category: Immunology | ||||||
| 08/23/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | CYLTEZO (Drug) | Food and Beverage | In-kind items and services | $30.44 | General |
| Category: CNS | ||||||
| 08/22/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/21/2023 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/16/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: Gastroenterology | ||||||
| 08/16/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: IMMUNOLOGY | ||||||
| 08/15/2023 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: IMMUNOLOGY | ||||||
| 08/14/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: Gastroenterology | ||||||
| 08/14/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Immunology | ||||||
| 08/14/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $8.91 | General |
| Category: Gastroenterology | ||||||
| 08/14/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $1.53 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 279 | 324 | $86,070 | $21,533 |
| 2022 | 7 | 429 | 495 | $138,807 | $36,877 |
| 2021 | 5 | 185 | 202 | $60,300 | $17,770 |
Total Patients
893
Total Services
1,021
Medicare Billing
$76,181
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 135 | 165 | $37,110 | $9,701 | 26.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 68 | 82 | $26,086 | $6,414 | 24.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 45 | 45 | $12,794 | $3,007 | 23.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $8,232 | $1,901 | 23.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 13 | $1,849 | $511.03 | 27.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 133 | 166 | $48,775 | $13,670 | 28.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 113 | 146 | $30,107 | $8,608 | 28.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 60 | 60 | $25,995 | $6,044 | 23.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 85 | 85 | $24,166 | $6,014 | 24.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 12 | 12 | $4,339 | $1,111 | 25.6% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 15 | 15 | $4,012 | $1,036 | 25.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 11 | 11 | $1,413 | $394.18 | 27.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 52 | 67 | $19,236 | $6,128 | 31.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 41 | 41 | $17,763 | $4,889 | 27.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 43 | 43 | $12,225 | $3,358 | 27.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 35 | 37 | $7,332 | $2,409 | 32.9% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 14 | 14 | $3,744 | $985.32 | 26.3% |
About Ellie Gonyeau
Ellie Gonyeau is a Family healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2020. The National Provider Identifier (NPI) number assigned to this provider is 1114541976.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ellie Gonyeau has received a total of $4,426 in payments from pharmaceutical and medical device companies, with $667.30 received in 2024. These payments were reported across 155 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($4,424).
As a Medicare-enrolled provider, Gonyeau has provided services to 893 Medicare beneficiaries, totaling 1,021 services with total Medicare billing of $76,181. Data is available for 3 years (2021–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Other Specialties Nurse Practitioner
- Location Boston, MA
- Active Since 06/07/2020
- Last Updated 10/18/2023
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1114541976
Products in Payments
- SKYRIZI (Biological) $566.95
- XIFAXAN (Drug) $518.18
- STELARA (Biological) $437.72
- CREON (Drug) $402.46
- ENTYVIO (Biological) $359.96
- CIMZIA (Drug) $347.39
- TREMFYA (Drug) $271.44
- ZENPEP (Drug) $253.34
- LINZESS (Drug) $250.64
- IBSRELA (Drug) $228.30
- MOTOFEN (Drug) $151.54
- DIFICID (Drug) $97.06
- SUTAB (Drug) $91.80
- DUPIXENT (Biological) $75.80
- ZEPOSIA (Drug) $73.92
- VIBERZI (Drug) $73.51
- RINVOQ (Biological) $47.45
- Kcentra (Biological) $35.79
- CYLTEZO (Drug) $30.44
- Physio-Stim (Device) $29.53
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Boston
Brittany Murray, Msn, Aprn, Fnp-Bc, MSN, APRN, FNP-BC
Family — Payments: $91,393
Family $91,393
Ms. Naomi Amudala, Np, NP
Family — Payments: $40,295
Family $40,295
Mrs. Alexa Costa, Np-C, NP-C
Family — Payments: $16,778
Family $16,778
Caitlin Murphy, Dnp, DNP
Family — Payments: $15,757
Family $15,757
Lauren Camillieri, Fnp-Bc, FNP-BC
Family — Payments: $7,681
Family $7,681
Charlene Sylvestre, N.p, N.P
Family — Payments: $6,498
Family $6,498